Quantcast

Latest Insulin therapy Stories

2014-09-11 23:06:37

Transparency Market Research published a new report "Global and China Insulin Market: Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume) 2013 - 2019" to its report store. Albany, New York (PRWEB) September 11, 2014 According to a new market report published by Transparency Market Research "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size,...

2014-09-05 16:22:59

LifeScienceIndustryResearch.com adds "Market Research Report on Global and Chinese Insulin (API & Injection) Industry, 2009-2019" to its store. DALLAS, Sept. 5, 2014 /PRNewswire-iReach/ -- This is a professional and in-depth market survey on Global and Chinese Insulin (API & Injection) industry. The report firstly reviews the basic information of Insulin (API & Injection) including its classification, application and manufacturing technology. The report then explores global...

2014-08-26 12:28:35

9 major insurance companies in Canada approved the reimbursement of the Montméd Timesulin under "standard group policies that include coverage for diabetic supplies". MONTREAL, Aug. 26, 2014 When it comes to diabetes supplies, innovations are often accused of having very little clinical relevance. But Timesulin happens to answer a real medical need. Fitting most of insulin disposable pen on the market, Timesulin shows how long it's been since your last injection. One advantage...

2014-08-20 23:09:43

The human insulin market is segmented based on types of insulin, and branded drugs available in the market (http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html). (PRWEB) August 20, 2014 The “Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2019” provides a...

2014-08-19 08:30:18

JERUSALEM, August 19, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Intellectual Property Department of Spain has granted the Company's patent for its invention, titled "Methods and Compositions for Oral Administrations of Proteins." About Oramed Pharmaceuticals Oramed Pharmaceuticals is a...

2014-08-18 16:23:39

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Insulin Resistance-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278599/-Insulin-Resistance-Pipeline-Insights-2014.htmlSUMMARYDelveInsight's," Insulin Resistance-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall...

Researchers Use Fruit Flies To Unlock Mysteries Of human Diabetes
2014-08-11 03:05:27

Stanford University Medical Center For the first time, the tiny fruit fly can be used to study how mutations associated with the development of diabetes affect the production and secretion of the vital hormone insulin. The advance is due to a new technique devised by researchers at the Stanford University School of Medicine that allows scientists to measure insulin levels in the insects with extremely high sensitivity and reproducibility. The experimental model is likely to...

2014-08-11 08:28:18

PARIS and VALENCIA, Calif., Aug. 11, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (Nasdaq: MNKD) announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza® (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. The companies plan to launch Afrezza in the United States in the first quarter of 2015. Under...

2014-08-05 17:20:56

Case Western Reserve University Case Western Reserve scientist helps lead study that will enhance insulin products and improve blood sugar control Since its landmark discovery in 1922, insulin has improved the health and extended the lives of more than 500 million people worldwide with diabetes mellitus. Yet the question of how this key hormone binds to its target cells in the body’s organs has posed an enduring scientific mystery. A global team of researchers from Cleveland,...

2014-07-25 12:24:51

ALBANY, New York, July 25, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume), 2013 - 2019", the global insulin market was valued at USD 19.99 billion in 2012 and is expected to grow at a CAGR of 6.1% from 2013 to 2019 to...


Latest Insulin therapy Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related